Chenguang Biotech Group Co.,Ltd.’s Net Profit Rose 27.7% in First Half of 2022

Chenguang Biotech Group Co.,Ltd. (晨光生物科技集团股份有限公司) (300138.SZ) reported a net profit of 240.4 million yuan in the first half of 2022, up 27.7% year-on-year.

Meanwhile, the company posted 3.2 billion yuan in revenue, up 53.7% year-on-year.

At the end of the reporting period, it had 6.2 billion yuan in total assets and 3.2 billion yuan in total liabilities, with a liability-to-asset ratio of 52%.